 This study is aimed at assessing the safety of candidate Hepatitis C Hep C vaccines AdCh3NSmut1 and MVA-NSmut when administered to Human Immunodeficiency Virus HIV seropositive individuals. This study also aims to assess the cellular immune response generated by these vaccines when administered as mentioned above. 